First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
Mitchell Senior Vice President of Regulatory Compliance Management Michele Hibbert-Iacobacci shared her thoughts and expertise with Claims Journal
As Americans practice social distancing to prevent further spread of COVID-19, it is important injured
As Americans practice social distancing to prevent further spread of COVID-19, it is important injured employees safely continue to receive the ser
On Wednesday, April 8, 2020, the New York State Workers' Compensation Board announced an extension of the formulary deadline for renewal prescripti